Article citationsMore>>
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T.P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., Cicarelli, G., Gaglio, R.M., Giglia, R.M., Iemolo, F., Manfredi, M., Meco, G., Nicoletti, A., Pederzoli, M., Petrone, A., Pisani, A., Pontieri, F.E., Quatrale, R., Ramat, S., Scala, R., Volpe, G., Zappulla, S., Bentivoglio, A.R., Stocchi, F., Trianni, G., Dotto, P.D. and PRIAMO Study Group (2009) The PRIAMO Study: A Multicenter Assessment of Nonmotor Symptoms and Their Impact on Quality of Life in Parkinson’s Disease. Movement Disorders, 24, 1641-1649.
http://dx.doi.org/10.1002/mds.22643
has been cited by the following article:
-
TITLE:
Safety and Efficacy of a Transdermal Rotigotine for the Treatment of Fatigue and Quality of Life in Patients with Parkinson’s Disease
AUTHORS:
Kazuo Abe, Masashi Fujita, Hiroo Yoshikawa
KEYWORDS:
Parkinson’s Disease, Non-Motor Symptoms, Fatigue, Quality of Life, Transdermal Rotigotine
JOURNAL NAME:
Advances in Parkinson's Disease,
Vol.4 No.4,
November
13,
2015
ABSTRACT: Aim: To evaluate safety and efficacy of a transdermal rotigotine for the treatment of fatigue and
quality of life (QOL) in patients with Parkinson’s disease (PD). This was a multi-sites open-label
study of 58 PD patients (male 26, female 32) who met a Japanese PD diagnosis criterion. They received
a transdermal rotigotine 4.5 mg/day for 8 weeks. We added a rotigotine on the previous
anti-Parkinson’s drugs. Clinical signs were evaluated by Hoehn-Yahr (H-Y) stage, unified Parkinson’s
disease rating scale (UPDRS), fatigue severity scale (FSS), and Euro quality of life (QOL). The
scores of UPDRS improved from 35.2 ± 8.0 (mean ± SD) to 31.8 ± 8.3 (P = 0.14). There was no significant
improvement or worsening of the H-Y stages. The scores of FSS improved from 57.3 ± 12.7
(mean ± SD) to 50.1 ± 11.8 (P = 0.061). The scores of QOL improved from 38.1 ± 11.1 to 48.3 ± 10.0
(P = 0.068). Our data demonstrate that, in a small sample size, administration of a transdermal rotigotine was associated with few side effects and was modestly effective for the treatment of fatigue
and QOL in patients with PD.
Related Articles:
-
Sarah Tasneem, Lester Lipsky, Reda Ammar, Howard Sholl
-
C. Aïnamon, M. J. S. Houndjo, A. A. L. Ayivi, M. G. Ganiou, A. Kanfon
-
Hadidjatou Bélem, Roland Nâg-Tiero Meda, Benjamin Kouliga Koama, Windmi Kagambéga, Sandrine Nadege Da, Anne Flora Drabo, Assetou Sawadogo, Cyprial Ndumiso Ncobela, Marie-Pierre Létourneau-Montminy, Amadou Traoré, George Anicet Ouédraogo
-
Karolj Skala, Davor Davidović, Tomislav Lipić, Ivan Sović
-
Roger Ellman